Status:
RECRUITING
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
Lead Sponsor:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Conditions:
CADASIL
CADASIL (Diagnosis)
Eligibility:
All Genders
18+ years
Brief Summary
Cerebrovascular diseases (CVDs) are one leading cause of morbidity and mortality worldwide. Despite intensive investigations, more than 30% of strokes remain of undetermined origin. Rare Cerebrovascul...
Eligibility Criteria
Inclusion
- patients with a clinical, genetic and/or neuroradiological diagnosis of rCVD (CADASIL, Fabry's disease, COL4A1, Sneddon's syndrome or Moyamoya arteriopathy), who have had at least one brain MRI study;
Exclusion
- na
Key Trial Info
Start Date :
May 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06935578
Start Date
May 1 2023
End Date
November 1 2025
Last Update
April 20 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Regionale Generale "F. Miulli", Acquaviva delle Fonti
Acquaviva delle Fonti, BA, Italy
2
ASST Melegnano Martesana
Melegnano, MI, Italy
3
Neurologia Stroke Unit dell'Asst Rhodense
Rho, Mi, Italy
4
Fondazione Istituto G. Giglio, Cefalù
Cefalù, PA, Italy